Search

Search Constraints

You searched for: Author/Creator Sleegers, Kristel

Search Results

1. [O2–08–06]: CONTRIBUTION OF RARE DELETERIOUS ABCA7 MUTATIONS TO A BELGIAN EARLY‐ONSET ALZHEIMER's DISEASE COHORT. (1st July 2017)

2. [O2–13–05]: DELETERIOUS ABCA7 MUTATIONS CONTRIBUTE TO EARLY‐ONSET ALZHEIMER's DISEASE AND ARE SUBJECT TO TRANSCRIPT RESCUE MECHANISMS. (1st July 2017)

3. [P2–116]: TRANSCRIPTOME ANALYSIS IN BLOOD AND BRAIN IDENTIFIES GENE EXPRESSION REGULATION AND CORRESPONDING QUANTITATIVE TRAIT LOCI IN ALZHEIMER's DISEASE. (1st July 2017)

4. A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42. Issue 12 (15th June 2015)

5. A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Issue 1 (1st January 2019)

6. A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats. Issue 2 (4th January 2013)

7. ABCA7 mutations are major contributors to Alzheimer's disease in Belgian patients: Genetics/genetic factors of Alzheimer's disease. (7th December 2020)

8. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Issue 5 (7th March 2019)

9. Convergent genetic and expression data implicate immunity in Alzheimer's disease. Issue 6 (19th December 2014)

10. C‐terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. Issue 12 (16th June 2015)